In another study evaluating the interaction between IRS-1 and MG53, normal individuals, obese insulin-resistant control subjects without diabetes, and patients with type 2 diabetes before and after insulin infusion were compared, and no difference was found in MG53 interaction with IRS-1 [33]. Here, INS is linked to type 2 diabetes mellitus.